170 related articles for article (PubMed ID: 25347946)
1. Acute kidney injury: cell cycle arrest biomarkers win race for AKI diagnosis.
Endre ZH; Pickering JW
Nat Rev Nephrol; 2014 Dec; 10(12):683-5. PubMed ID: 25347946
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle arrest biomarkers: new weapons for a new battle.
Ronco C
Blood Purif; 2014; 38(3-4):I-III. PubMed ID: 25678359
[No Abstract] [Full Text] [Related]
3. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
[TBL] [Abstract][Full Text] [Related]
4. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.
Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T
PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery.
Gist KM; Goldstein SL; Wrona J; Alten JA; Basu RK; Cooper DS; Soranno DE; Duplantis J; Altmann C; Gao Z; Faubel S
Pediatr Nephrol; 2017 Sep; 32(9):1611-1619. PubMed ID: 28382566
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.
Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
9. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle arrest and acute kidney injury: the light and the dark sides.
Kellum JA; Chawla LS
Nephrol Dial Transplant; 2016 Jan; 31(1):16-22. PubMed ID: 26044835
[TBL] [Abstract][Full Text] [Related]
11. A promising marker in early diagnosis of septic acute kidney injury of critically ill patients: urine insulin like growth factor binding protein-7.
Aydoğdu M; Boyacı N; Yüksel S; Gürsel G; Sivri AB
Scand J Clin Lab Invest; 2016 Sep; 76(5):402-10. PubMed ID: 27240440
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
13. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.
Hoste EA; McCullough PA; Kashani K; Chawla LS; Joannidis M; Shaw AD; Feldkamp T; Uettwiller-Geiger DL; McCarthy P; Shi J; Walker MG; Kellum JA;
Nephrol Dial Transplant; 2014 Nov; 29(11):2054-61. PubMed ID: 25237065
[TBL] [Abstract][Full Text] [Related]
14. Improving clinical prediction rules in acute kidney injury with the use of biomarkers of cell cycle arrest: a pilot study.
Hodgson LE; Venn RM; Short S; Roderick PJ; Hargreaves D; Selby N; Forni LG
Biomarkers; 2019 Feb; 24(1):23-28. PubMed ID: 29943653
[TBL] [Abstract][Full Text] [Related]
15. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
[TBL] [Abstract][Full Text] [Related]
16. The concept of risk and the value of novel markers of acute kidney injury.
Ronco C; Ricci Z
Crit Care; 2013 Feb; 17(1):117. PubMed ID: 23409754
[TBL] [Abstract][Full Text] [Related]
17. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.
Meersch M; Schmidt C; Van Aken H; Martens S; Rossaint J; Singbartl K; Görlich D; Kellum JA; Zarbock A
PLoS One; 2014; 9(3):e93460. PubMed ID: 24675717
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury.
Bell M; Larsson A; Venge P; Bellomo R; Mårtensson J
Dis Markers; 2015; 2015():158658. PubMed ID: 25866432
[TBL] [Abstract][Full Text] [Related]
19. Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.
Schanz M; Wasser C; Allgaeuer S; Schricker S; Dippon J; Alscher MD; Kimmel M
Nephrol Dial Transplant; 2019 Nov; 34(11):1902-1909. PubMed ID: 29961888
[TBL] [Abstract][Full Text] [Related]
20. Will urinary biomarkers provide a breakthrough in diagnosing cardiac surgery-associated AKI? - A systematic review.
Hussain ML; Hamid PF; Chakane N
Biomarkers; 2020 Jul; 25(5):375-383. PubMed ID: 32479185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
